 - Drugs that are strong inhibitors or inducers of CYP3A or CYP2C8, p-glycoprotein Pgp or Bcrp transporter because they may alter dabrafenib concentrations. The list may be modified based on emerging data. These include but are not limited to those listed in Appendix 2; consider therapeutic substitutions for these medications. 